[HTML][HTML] Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks
M Katoh - International journal of molecular medicine, 2013 - spandidos-publications.com
Angiogenesis is a process of neovascular formation from pre-existing blood vessels, which
consists of sequential steps for vascular destabilization, angiogenic sprouting, lumen …
consists of sequential steps for vascular destabilization, angiogenic sprouting, lumen …
Challenges in elucidating the genetics of diabetic retinopathy
JZ Kuo, TY Wong, JI Rotter - JAMA ophthalmology, 2014 - jamanetwork.com
Importance In the past decade, significant progress in genomic medicine and technologic
developments has revolutionized our approach to common complex disorders in many …
developments has revolutionized our approach to common complex disorders in many …
Association between the vascular endothelial growth factor single nucleotide polymorphisms and diabetic retinopathy risk: A meta‐analysis: 关于血管内皮生长因子单 …
XJ Xie, YM Yang, JK Jiang, YQ Lu - Journal of Diabetes, 2017 - Wiley Online Library
背景这项研究的目的是揭示血管内皮生长因子(vascular endothelial growth factor, VEGF)
单核苷酸多态性(single nucleotide polymorphisms, SNPs) 和糖尿病视网膜病变(diabetes …
单核苷酸多态性(single nucleotide polymorphisms, SNPs) 和糖尿病视网膜病变(diabetes …
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study
M Scartozzi, L Faloppi… - … journal of cancer, 2014 - Wiley Online Library
Although new treatment modalities changed the global approach to hepatocellular
carcinoma (HCC), this disease still represents a medical challenge. Currently, the …
carcinoma (HCC), this disease still represents a medical challenge. Currently, the …
[HTML][HTML] Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness
Purpose To investigate the role of serum inflammatory cytokines and vascular endothelial
growth factor (VEGF) in diabetic retinopathy (DR) and evaluate their relationship with …
growth factor (VEGF) in diabetic retinopathy (DR) and evaluate their relationship with …
Do genomic factors play a role in diabetic retinopathy?
AP Cabrera, F Monickaraj, S Rangasamy… - Journal of clinical …, 2020 - mdpi.com
Although there is strong clinical evidence that the control of blood glucose, blood pressure,
and lipid level can prevent and slow down the progression of diabetic retinopathy (DR) as …
and lipid level can prevent and slow down the progression of diabetic retinopathy (DR) as …
Six novel loci associated with circulating VEGF levels identified by a meta-analysis of genome-wide association studies
Vascular endothelial growth factor (VEGF) is an angiogenic and neurotrophic factor,
secreted by endothelial cells, known to impact various physiological and disease processes …
secreted by endothelial cells, known to impact various physiological and disease processes …
Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels
S Debette, S Visvikis-Siest, MH Chen… - Circulation …, 2011 - Am Heart Assoc
Rationale: Vascular endothelial growth factor (VEGF) affects angiogenesis, atherosclerosis,
and cancer. Although the heritability of circulating VEGF levels is high, little is known about …
and cancer. Although the heritability of circulating VEGF levels is high, little is known about …
The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta‐analysis of 11 case‐control studies
L Han, L Zhang, W Xing, R Zhuo, XL Lin… - Journal of diabetes …, 2014 - Wiley Online Library
Aims. Published data on the associations of VEGF polymorphisms with diabetic retinopathy
(DR) susceptibility are inconclusive. A systematic meta‐analysis was undertaken to clarify …
(DR) susceptibility are inconclusive. A systematic meta‐analysis was undertaken to clarify …
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
Background: Currently, sunitinib represents one of the therapeutic strongholds for renal cell
carcinoma, but the criteria for treatment selection are lacking. We assessed the role of …
carcinoma, but the criteria for treatment selection are lacking. We assessed the role of …